TIM recognition of PtdSer on apoptotic cells and the regulation of immunity

TIM对凋亡细胞PtdSer的识别及免疫调节

基本信息

  • 批准号:
    8704253
  • 负责人:
  • 金额:
    $ 42.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

The TIM gene family was identified using a congenic mouse model in which polymorphisms in TIM-1 and TIM-3 were associated with differences in Th1-Th2 differentiation and allergen-induced airway hyperreactivity (AHR) between BALB/c and congenic HBA mice. Our goal is to understand how the Tim genes regulate peripheral tolerance, adaptive immune responses, and allergy. We have shown that TIM-1 is an important costimulatory molecule for T cells, that TIM-1 and TIM-4 regulate T cell responses and the development of tolerance, and that TIM-1 and TIM-4 are receptors for phosphatidylserine (PtdSer), a key molecule for recognition and uptake of apoptotic cells. We have recently found that TIM-3, expressed on Th1 cells and APC, is also a receptor for PtdSer and that the allelic variants of TIM-3 associated with asthma differ in binding to PtdSer. These results suggest a new paradigm for TIM proteins as PtdSer receptors that by regulating the recognition, clearance, and response to apoptotic cells, can regulate T cell responses and the induction of peripheral tolerance. To understand how TIM protein recognition of PtdSer regulates immune responses, we propose to: Specific Aim 1: Determine the functional consequences of TIM-4 and TIM-3 on APC binding to phosphatidylserine on apoptotic cells. We will examine effects of apoptotic cell engulfment on DCs and macrophages including (a) anti-inflammatory mediator production: IL-10, TGF-B, IDO; (b) expression of co-inhibitory molecules; and (c) expression of co-stimulatory molecules. We will determine the effects of TIM-4- and TIM-3 mediated phagocytosis of apoptotic cell antigen on TReg and T helper subset development. Specific Aim 2. Determine the structure/function relationship of TIM allelic variants on recognition of phosphatidylserine, phagocytosis, and T cell activation. We will determine if cells expressing HBA and BALB/c alleles of TIM-1 and TIM-3 have different capacities to recognize PtdSer and phagocytose apoptotic cells. We will determine how binding of PtdSer on an apoptotic cell to TIM-1 and TIM-3 on a T cell regulates T cell activation and TReg development, and compare BALB/c and HBA T cells. Specific Aim 3: Investigate the in vivo role of TIM-1 and TIM-3 allelic variants in immune responses and regulation of peripheral tolerance. We will compare the roles of the TIM-3 pathway in clearance of apoptotic cells in vivo and in the presentation of apoptotic cell-associated antigen in BALB/c and HBA mice. We will determine the relative roles of TIM-1 and TIM-3 in regulating the development of AHR in BALB/c and HBA mice. These studies will greatly increase our understanding of the function of TIMs in the regulation of T cell responses and tolerance, and characterize a novel and extremely important asthma susceptibility gene family.
TIM基因家族是使用同源小鼠模型鉴定的,在该模型中,TIM-1和TIM-1基因的多态 TIM-3与Th1-Th2分化差异和变应原诱导的呼吸道高反应性有关 (AHR)在BALB/c小鼠和同源HBA小鼠之间。我们的目标是了解Tim基因是如何调控的 外周耐受性、适应性免疫反应和过敏。我们已经证明TIM-1是一种重要的 T细胞共刺激分子TIM-1和TIM-4调节T细胞反应和TIM-4 TIM-1和TIM-4是磷脂酰丝氨酸(PtdSer)的受体,磷脂酰丝氨酸是PtdSer的关键分子 对凋亡细胞的识别和吸收。我们最近发现TIM-3,表达在Th1细胞和 APC,也是PtdSer的受体,与哮喘相关的TIM-3的等位基因变体在结合方面有所不同 致PtdSer。这些结果提示了一种新的TIM蛋白作为PtdSer受体的范例,即通过调节 对凋亡细胞的识别、清除和反应,可以调节T细胞的反应和诱导 外围设备容忍度。为了了解PtdSer的Tim蛋白质识别如何调节免疫反应,我们 建议: 具体目标1:确定TIM-4和TIM-3对APC结合的功能影响 磷脂酰丝氨酸对凋亡细胞的影响。我们将研究凋亡细胞吞噬DC和 巨噬细胞包括:(A)抗炎介质的产生:IL-10、转化生长因子-β、IDO;(B)共抑制的表达 以及(C)共刺激分子的表达。我们将确定TIM-4的效果- TIM-3介导的凋亡细胞抗原对Treg和T辅助细胞亚群发育的吞噬作用。 特定目的2.确定TIM等位基因变异体的结构/功能关系 磷脂酰丝氨酸、吞噬作用和T细胞活化。我们将确定表达HBA和HBA的细胞 TIM-1和TIM-3的Balb/c等位基因识别PtdSer和吞噬细胞凋亡的能力不同 细胞。我们将确定凋亡细胞上的PtdSer与T细胞上的TIM-1和TIM-3的结合如何调节T细胞 细胞活化和Treg发育,并比较BALB/c和Hba T细胞。 特异性目标3:研究TIM-1和TIM-3等位基因变异在免疫应答中的体内作用 和外周耐受性的调节。我们将比较TIM-3通路在清除 BALB/c和HBA小鼠体内的凋亡细胞和凋亡细胞相关抗原的呈递。 我们将确定TIM-1和TIM-3在调节AHR在BALB/c和BALB/c中的相对作用。 HBA小鼠。 这些研究将极大地加深我们对TIMs在T细胞调节中的功能的理解 反应和耐受性,并表征了一个新的和极其重要的哮喘易感基因家族。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Abundant PD-L1 expression in Epstein-Barr Virus-infected gastric cancers.
  • DOI:
    10.18632/oncotarget.9076
  • 发表时间:
    2016-05-31
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Derks S;Liao X;Chiaravalli AM;Xu X;Camargo MC;Solcia E;Sessa F;Fleitas T;Freeman GJ;Rodig SJ;Rabkin CS;Bass AJ
  • 通讯作者:
    Bass AJ
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rosemarie H DeKruyff其他文献

Rosemarie H DeKruyff的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rosemarie H DeKruyff', 18)}}的其他基金

TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
  • 批准号:
    8495892
  • 财政年份:
    2010
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
  • 批准号:
    8082683
  • 财政年份:
    2010
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
  • 批准号:
    7949426
  • 财政年份:
    2010
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM recognition of PtdSer on apoptotic cells and the regulation of immunity
TIM对凋亡细胞PtdSer的识别及免疫调节
  • 批准号:
    8288920
  • 财政年份:
    2010
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
  • 批准号:
    8306826
  • 财政年份:
    2003
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
  • 批准号:
    7995554
  • 财政年份:
    2003
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
  • 批准号:
    8380754
  • 财政年份:
    2003
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
  • 批准号:
    8831793
  • 财政年份:
    2003
  • 资助金额:
    $ 42.74万
  • 项目类别:
TIM-1, TIM-3 and TIM-4: A gene family that regulates tolerance and immunity
TIM-1、TIM-3 和 TIM-4:调节耐受性和免疫性的基因家族
  • 批准号:
    8507123
  • 财政年份:
    2003
  • 资助金额:
    $ 42.74万
  • 项目类别:
Differential Activation Requirements of CD4+ T Cells
CD4 T 细胞的差异激活要求
  • 批准号:
    6382727
  • 财政年份:
    2001
  • 资助金额:
    $ 42.74万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 42.74万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 42.74万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 42.74万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 42.74万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 42.74万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 42.74万
  • 项目类别:
    Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 42.74万
  • 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 42.74万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 42.74万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 42.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了